Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From General Anesthesia
This study has been completed.
Information provided by:
First received: March 4, 2010
Last updated: November 18, 2010
Last verified: November 2010
Target concentration infusion(TCI) of remifentanil (2.0ng/ml) suppresses the cough induced by endotracheal tube more effectively than intravenous administration of lidocaine (1.5mg/kg).
Drug: remifentanil / lidocaine
||Primary Purpose: Prevention
||Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From General Anesthesia
Primary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||July 2010 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||20 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Females older than 20 years old
- Patients with acute or chronic respiratory disease, hypertension, gastro-esophageal reflux disease, having preoperative sedatives or mucolytics, and current smoker.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01082458
|Seoul, Korea, Republic of |
No publications provided
||Jung-Lim Lee / Assistant Professor, Anesthesiology and Pain Medicine
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 4, 2010
||November 18, 2010
||Korea: Food and Drug Administration
Keywords provided by Yonsei University:
Patients scheduled to undergo thyroidectomy
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 28, 2014
Central Nervous System Depressants
Physiological Effects of Drugs
Central Nervous System Agents
Sensory System Agents
Peripheral Nervous System Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Hypnotics and Sedatives